News Conference News AHA 2025 DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation Todd Neale November 12, 2025
News Daily News Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More Michael O'Riordan December 06, 2024
News Conference News AHA 2024 Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF Shelley Wood November 18, 2024
News Conference News TCT 2024 LAAO Outcomes Similar Regardless of Operator’s Specialty Todd Neale October 27, 2024
News Conference News HRS 2024 Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus Michael O'Riordan May 23, 2024
News Conference News ESC 2023 ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More Michael O'Riordan September 06, 2023
News Conference News ESC 2022 ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death Todd Neale September 02, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2022 Caitlin E. Cox July 04, 2022
News Conference News HRS 2021 Catheter Ablation ‘Good Value’ in CABANA Economic Analysis Michael O'Riordan August 04, 2021
News Conference News HRS 2021 Progestin OCs Triple CV Events in Women With Congenital Long QT Caitlin E. Cox July 30, 2021
News Daily News CABANA Supports Use of AF Ablation in Patients With Heart Failure Todd Neale February 12, 2021
News Conference News ESC 2020 Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care Shelley Wood August 30, 2020
News Conference News EHRA 2019 Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned Todd Neale March 26, 2019
News Daily News Long-Awaited CABANA Publication Arrives, With Accompanying Quality-of-Life Study Todd Neale March 15, 2019
News Daily News Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests Todd Neale February 01, 2019
News Conference News HRS 2018 CABANA Misses Primary Endpoint, but Electrophysiologists See Support for Ablation Todd Neale May 10, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Daily News Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide Michael O'Riordan June 08, 2016